Reliability and Validation of MSCEIT to Evaluate Emotional Intelligence for Chronic Kidney Disease Patients

OBJECTIVE: To evaluate the reliability and validate the method used to test for emotional intelligence (EI) among CKD patients. METHODOLOGY: This study was conducted in a public hospital for patients with kidney disease. A total of 30 CKD patients were included in this study using the flat rule of thumb and data collected from June until July 2023. The Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) question booklet was used in both English and Malay for this study to evaluate the level of EI in CKD patients. The obtained data was analyzed using SPSS and AMOS software. RESULTS: Most respondents were female, n=17 (56.7%) and Male, n=13 (43.3%). The mean results for MSCEIT indicate that the highest score is for the face component, and the lowest is for sensation. The branches of EI were measured, and the Goodness Fit Index (GFI) is accepted at 0.917, the RMSEA value is at 0.024, and TLI is accepted at 0.993. The Cronbach alpha for MSCEIT is 0.807 for 30 patients with eight categories of items. The Goodness Fit Index is accepted at the value of 0.917, RMSEA 0.024 is accepted, and TLI is accepted at 0.993. CONCLUSION: Overall, the results of the present study suggest that MSCEIT can be used for other medical conditions for bigger-scale research to evaluate the psychological aspect for further treatment.